Hydrothermal reactions of manganese(II) salts with m-sulfophenylphosphonic acid (m-HO3S-Ph-PO3H2, H3L) and 1,10-phenanthroline (phen) led to six novel manganese(II) sulfonate-phosphonates, namely, [Mn2(HL)2(phen)4][Mn2(HL)2(phen)4(H2O)](2).6H2O (1), [Mn4(L)2(phen)8(H2O)2][ClO4](2).3H2O (2), [Mn(phen)(H2O)4]2[Mn4(L)4(phen)4].10H2O (3), [Mn6(L)4(phen)8(H2O)2].4H2O (4), [Mn6(L)4(phen)8(H2O)2].24H2O (5), and [Mn6(L)4(phen)6(H2O)4].5H2O (6). The structure of 1 contains two types of dinuclear manganese(II) clusters, and 2-3 exhibit two types of tetranuclear manganese(II) cluster units. 4-5 feature two different types of isolated hexanuclear manganese(II) clusters, whereas the hexanuclear manganese(II) clusters in 6 are bridged by sulfonate-phosphonate ligands into a 1D chain. Magnetic property measurements indicate that there exist weak antiferromagnetic interactions between magnetic centers in all six compounds.
No takes yet. Share an insight, caveat, or question.
Du et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: